Intraductal carcinoma (IC) is the new World Health Organization designation for tumors previously called "low-grade cribriform cystadenocarcinoma" and "low-grade salivary duct carcinoma." The relationship of IC to salivary duct carcinoma is controversial, but they now are considered to be distinct entities. IC is a rare low-grade malignant salivary gland neoplasm with features similar to mammary atypical ductal hyperplasia or ductal carcinoma in situ, that shows diffuse S100 protein and mammaglobin positivity and is only partially defined genetically. (Mammary analogue) secretory carcinoma harboring ETV6-NTRK3, and in rare cases ETV6-RET fusion, shares histomorphologic and immunophenotypical features with IC. Recently, RET rearrangements and NCOA4-RET have been described in IC, suggesting a partial genetic overlap with mammary analogue secretory carcinoma. Here, we genetically characterize the largest cohort of IC to date to further explore this relationship. Seventeen cases of IC were analyzed by next-generation sequencing using the FusionPlex Solid Tumor kit (ArcherDX). Identified fusions were confirmed using fluorescence in situ hybridization break apart and, in some cases, fusion probes, and a reverse transcription polymerase chain reaction designed specifically to the detected breakpoints. All analyzed cases were known to be negative for ETV6 rearrangement by fluorescence in situ hybridization and for ETV6-NTRK3 fusion by reverse transcription polymerase chain reaction. Next-generation sequencing analysis detected a NCOA4-RET fusion transcript joining exon 7 or 8 of NCOA4 gene and exon 12 of RET gene in 6 cases of intercalated duct type IC; and a novel TRIM27-RET fusion transcript between exons 3 and 12 in 2 cases of salivary gland tumors displaying histologic and immunohistochemical features typical of apocrine IC. A total of 47% of IC harbored a fusion involving RET. In conclusion, we have confirmed the presence of NCOA4-RET as the dominant fusion in intercalated duct type IC. A novel finding in our study has been a discovery of a subset of IC patients with apocrine variant IC harboring a novel TRIM27-RET.

Department of Oral Pathology Faculty of Dentistry University of São Paulo São Paulo Brazil

Department of Pathology Charles University Faculty of Medicine in Plzen

Department of Pathology G Pompidou Hospital Paris APHP Paris Descartes University Paris France

Department of Pathology IRCCS San Raffaele Scientific Institute Milan Italy

Department of Pathology Toulouse University Hospital

Department of Pathology University Health Network Toronto ON Canada

Department of Pathology UT Southwestern Medical Center Dallas TX

Histopathology Department Addenbrooke Hospital Cambridge University Hospitals NHS Trust Cambridge UK

INSERM U1037 Cancer Research Center of Toulouse Toulouse

Molecular and Genetic Laboratory Biopticka Laboratory Ltd Plzen

Southern California Permanente Medical Group Woodland Hills CA

The Fingerland Department of Pathology Charles University Faculty of Medicine and University Hospital Hradec Kralove Czech Republic

References provided by Crossref.org

Oncocytic Tumors in the Salivary Gland: Cytopathological, Pathological, and Molecular Features

Oncocytic intraductal carcinoma of parotid gland with a novel AGK::BRAF gene fusion

Proceedings of the North American Society of Head and Neck Pathology Companion Meeting, New Orleans, LA, March 12, 2023: Classification of Salivary Gland Tumors: Remaining Controversial Issues?

Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Salivary Glands

ALK alterations in salivary gland carcinomas